Hypertension is an infrequently reported side effect of sorafenib in children (16, 19) even though it is common in adults (27) and mostly manageable with the use of angiotensin-converting enzyme inhibitors and beta-blockers. The gene discussed is ACE; the disease is hypertensive disorder.